MoneyMarketWatch
Novo Nordisk strikes second licensing deal since frosty capital-markets day
Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor reception from investors after presenting its long-term strategy.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor reception from investors after presenting its long-term strategy.
Join the argument
House rules →Comments load as you scroll.